| AD | Alzheimer’s disease |
| ADAPT | Alzheimer’s Disease Anti-Inflammatory Prevention Trial |
| APOE | apolipoprotein E 4 |
| ARIA | Amyloid-Related Imaging Abnormalities |
| ASC | apoptosis-associated speck-like protein containing caspase recruitment domains |
| Aβ | amyloid-beta |
| BBB | blood–brain barrier |
| C1q | complement component 1q |
| CB | cannabinoid receptor |
| CCL3/4 | macrophage inflammatory protein1α/β |
| CD33 | cluster of differentiation 33 |
| CD68 | cluster of differentiation 68 |
| CD83 | cluster of differentiation 83 |
| ChIP-Seq | chromatic immunoprecipitation sequencing |
| CNS | central nervous system |
| CRISPR | clustered regularly interspaced short palindromic repeats |
| CSF | cerebrospinal fluid |
| CSP | canonical senescence pathway |
| CST7 | cystatin F |
| CX3CR1 | cell surface chemokine receptor 1 |
| CyTOF | comprehensive multiplexed mass cytometry |
| DAM | disease-associated microglia |
| DNA | deoxyribonucleic acid |
| ER | endoplasmic reticulum |
| GWAS | genome-wide association studies |
| HIF1α | mTOR-hypoxia-inducible factor-1α |
| IBA1 | ionized calcium-binding adapter molecule 1 |
| IFI16 | interferon gamma inducible protein 16 |
| IMG | human hPSC-derived microglia |
| IRF8 | interferon regulatory factor 8 |
| ITGAX; CD11c | integrin subunit alpha X |
| JAK | Janus kinases |
| LDAM | Lipid droplet accumulation microglia |
| LPL | lipoprotein lipase |
| mAbs | monoclonal antibodies |
| MCI | mild cognitive impairment |
| MGnD | microglial neurodegenerative phenotype |
| MHC | major histocompatibility complex |
| miRNA, miR | microRNAs |
| MMSE | Mini-Mental State Examination |
| MRI | magnetic resonance imaging |
| MRs | master transcriptional regulators |
| mTOR | mechanistic target of rapamycin |
| NFKB1 | nuclear factor kappa b subunit 1 |
| NFTs | neurofibrillary tangles |
| NK | natural killer |
| NLRP3 | NOD-like receptor family, pyrin domain-containing 3 |
| NSAIDS | non-steroidal anti-inflammatory drugs |
| OPCs | oligodendrocyte progenitor cells |
| p16 | cyclin-dependent kinase inhibitor 2A/p16INK4A |
| P22 | subtype-selective sialic acid mimetic |
| P2RY12 | purinergic receptor P2Y, G-protein coupled, 12 |
| P2X7R | purinergic P2X7 receptor |
| p38 MAPK | p38 mitogen activated protein kinase |
| PD-1 | programmed cell death protein 1 |
| PET | positron emission tomography |
| PLIN2 | lipid droplet surface protein perilipin 2 |
| PPARy | peroxisome proliferator-activated receptor gamma |
| PS19 | mouse tauopathy model expressing MAPT P301S |
| PU.1 | purine rich box binding protein 1 |
| RONS | reactive oxygen and nitrogen species |
| ROS | reactive oxygen species |
| RUNX1 | runt-related transcription factor 1 |
| SASP | senescence-associated secretory phenotype |
| SA-β-gal | senescence-associated β-galactosidase |
| scRNA-seq | single-cell RNA sequencing |
| SIRT1 | sirtuin 1 |
| snRNA-seq | single-nucleus RNA sequencing |
| STAT | signal transducer and activator of transcription proteins |
| sTNF | soluble TNF |
| TAL1 | T-cell acute lymphocytic leukemia protein 1 |
| TGFB | transforming growth factor-β |
| TMEM119 | transmembrane protein 119 |
| TNF | tumor necrosis factor |
| TREM2 | Triggering receptor expressed on myeloid cells 2 |
| TREM2+/− | TREM2 haplodeficiency |
| TYROBP | TYRO protein tyrosine kinase binding protein |
| WHO | World Health Organization |